PT  - JOURNAL ARTICLE
AU  - Lakshmi Karra
AU  - Allison Costello
AU  - Brooke M. Trudeau
AU  - Morteza Khodaee
TI  - Are Boosters Necessary If Adult Patients Do Not Achieve Seroconversion After 2 Doses of the MMR Vaccine?
AID  - 10.3122/jabfm.2022.220285R1
DP  - 2023 Jan 02
TA  - The Journal of the American Board of Family
                Medicine
PG  - jabfm.2022.220285R1
4099  - http://www.jabfm.org/content/early/2023/01/02/jabfm.2022.220285R1.short
4100  - http://www.jabfm.org/content/early/2023/01/02/jabfm.2022.220285R1.full
AB  - The Centers for Disease Control (CDC) recommend 2 documented doses of the MMR (measles-mumps-rubella) vaccine for adequate measles, mumps, and rubella immunity for all children and most adults. Sometimes, individuals are asked to provide serologic proof of immunity to measles, mumps, and/or rubella for educational or employment purposes. In other instances, serologic testing may be used to help clarify whether an individual has immunity to measles, mumps, and/or rubella. These serologic tests may sometimes show negative or equivocal antibody titers to measles, mumps and/or rubella, raising the question of adequate immunity. This report provides practical guidance for clinicians on when to use serologic testing to determine measles, mumps, and rubella immunity.